Muscle is the largest organ system of the body, comprising approximately 30% of body mass. Muscle is considered one of the most adaptable tissues, responding quickly to use and disuse, and is capable of regeneration, hypertrophy, and alteration of metabolic status over relatively short periods of time. Muscle dysfunction is an important human health problem. Inherited disorders of muscle, composed primary of muscular dystrophies of the most common and most devastating inborn errors of human metabolism. Weakness due to aging (sarcopenia), and during space travel are also major concerns regarding the loss of muscle function. There are clearly many advantages of muscle as an organ system in which to test the ability of exogenously added genes to modulate cellular function. However, as the muscle gene delivery field as expanded and matured over the last few years, significant hurdles facing practical applications have become recognized. It is these remaining hurdles that are the focus of this program project. In this program project, we combine the complementary expertise of a group of seven independent investigators who have a track-record of synergistic collaboration, and commitment to the field of muscle, muscle disease, and muscle gene delivery. The interdependency of the different projects and sponsoring laboratories is evident through the extensive collaborative preliminary data that is presented, a long history of co- authored publications, and established shared training grants, group meetings, and journal clubs. Research projects are as follows: Project 1 (Dr. Xiao), adeno-associated virus (AAV) vectors to improve mature muscle function by gene delivery. Project 2 (Dr. Clemens), Long-term rescue of muscle function by dystrophin delivery using novel adenoviral vectors. Project 3 (Dr. Huard), Definition and circumvention of maturation-dependent infectivity of muscle by adenovirus. Project 4 (Dr. Hoffman), Development of targeting ligands for systemic delivery to muscle. Three Cores support the research projects; Administrative Core (Dr. Hoffman), Muscle Physiology Core (Dr. Watchko), and Mouse Breeding Core (Dr. Clemens).

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAR1-JRL-A (J2))
Program Officer
Lymn, Richard W
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Other Health Professions
Schools of Pharmacy
United States
Zip Code
Reay, D P; Bilbao, R; Koppanati, B M et al. (2008) Full-length dystrophin gene transfer to the mdx mouse in utero. Gene Ther 15:531-6
Zhang, Jing-Shi; Liu, Feng; Conwell, Christine C et al. (2006) Mechanistic studies of sequential injection of cationic liposome and plasmid DNA. Mol Ther 13:429-37
Bilbao, Roberto; Reay, Daniel P; Li, Juan et al. (2005) Patterns of gene expression from in utero delivery of adenoviral-associated vector serotype 1. Hum Gene Ther 16:678-84
Conwell, Christine C; Huang, Leaf (2005) Recent advances in non-viral gene delivery. Adv Genet 53:3-18
Deasy, B M; Gharaibeh, B M; Pollett, J B et al. (2005) Long-term self-renewal of postnatal muscle-derived stem cells. Mol Biol Cell 16:3323-33
Bilbao, R; Reay, D P; Wu, E et al. (2005) Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero. Gene Ther 12:39-47
Liang, K W; Nishikawa, M; Liu, F et al. (2004) Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA. Gene Ther 11:901-8
Cao, Baohong; Huard, Johnny (2004) Muscle-derived stem cells. Cell Cycle 3:104-7
Kimura, Shigemi; Ikezawa, Makoto; Cao, Baohong et al. (2004) Ex vivo gene transfer to mature skeletal muscle by using adenovirus helper cells. J Gene Med 6:155-65
Cao, B; Bruder, J; Kovesdi, I et al. (2004) Muscle stem cells can act as antigen-presenting cells: implication for gene therapy. Gene Ther 11:1321-30

Showing the most recent 10 out of 52 publications